Definitive haematopoiesis in the fetal liver supports self-renewal and differentiation of haematopoietic 76 stem cells/multipotent progenitors (HSC/MPPs), yet remains poorly defined in humans. Using single 77 cell transcriptome profiling of ~133,000 fetal liver and ~65,000 fetal skin and kidney cells, we identify 78 the repertoire of blood and immune cells in first and early second trimesters of development. From this 79 data, we infer differentiation trajectories from HSC/MPPs, and evaluate the impact of tissue 80 microenvironment on blood and immune cell development. We predict coupling of mast cell 81 differentiation with erythro-megakaryopoiesis and identify physiological erythropoiesis in fetal skin. 82
Single cell transcriptome map of fetal liver 145
To investigate blood and immune cell development in the fetal liver, we generated single cell 146 suspensions from embryonic and fetal livers between 6 and 18 PCW. We FACS-isolated cells for 147 droplet-based (10x Genomics) and indexed plate-based (Smart-seq2) single cell RNA sequencing 148 (scRNA-seq) (Figure 1a In total, we performed scRNA-seq of 145,040 cells from liver of which 133,756 passed QC (111,886 156 cells using 3'kit and 21,870 cells using 5' V(D)J kit; n = 13), 56,800 cells from skin with 56,771 passing 157 QC (n = 8), and 9,171 cells from kidney with 9,115 passing QC (n = 4) ( Figure 1b and Extended Data 158 Table 2 ). An additional 3,571 fetal liver, skin and kidney cells from 9-12 PCW were profiled using the 159 Smart-seq2 protocol (Extended Data Table 1 ). We detected on average ~3,000 genes per cell with the 160 10x Genomics platform and ~6,000 genes with the Smart-seq2 protocol (see Methods). We excluded 161 cells with <200 genes, >20% mitochondrial gene expression and those identified as doublets (see 162 Methods). 163 164 Our fetal liver dataset comprises 13 karyotypically normal fetuses: seven female and six male (Extended 165 Data Figure 1a ). The presence of maternal cells was excluded using genotyping from mRNA reads (see 166 Methods). We performed graph-based Louvain clustering on 111,886 single cell transcriptomes 167 generated by 10x 3'kit and derived marker genes to annotate the cell clusters (see Methods, Figure 1c ). 168
Consistency and agreement of cell clusters was additionally evaluated with a non-graph-based 169 clustering method (Gaussian mixture) and a second graph-based (Agglomerative with Ward linkage) 170 clustering method (Extended Data Figure 1b ). Batch alignment was performed using Canonical 171 Correlation Analysis 13 and was visualised by UMAP. 28 major cell types were identified in the fetal 172 liver (Figure 1c ). We annotated cell types by cross-referencing cluster-defining transcripts with 173 published literature reports of these genes and their cell-type specific expression (see Methods). We 174 applied a descriptive nomenclature for these cell types based on their gene expression profile. 175
176
To evaluate fetal liver cell populations across developmental stages, we defined four gestational phases 177 spanning the first and second trimesters: 6-9 PCW (40,194 cells; n = 4), 9-12 PCW (33,055 cells; n = 178 4), 12-15 PCW (30,775 cells, n=2), and 15-18 PCW (29,514 cells, n=3) ( Figure 1b ), and calculated the 179 relative frequency of cell states during each phase (Figure 1d ). All 28 cell states are present throughout 180 6 these stages ( Figure 1d and Extended Data Figure 1c ) with 26/28 cell states represented in the sparser 181 Smart-seq2 dataset (Extended Data Figure 1d ). We did not detect neutrophils, basophils or eosinophils 182 in the fetal liver, which is consistent with reports of granulocytes developing later during fetal BM 183 haematopoiesis 14 . Our findings agree with previous reports on erythroid lineage bias in early fetal liver, 184 and an increasing prominence of lymphoid and myeloid lineages with advancing gestation (Figure 1d We provide a comprehensive expression profile of genes known to cause primary immunodeficiencies 15 188 in the 28 inferred fetal liver cell types. The expression patterns of these genes will provide insight on 189 the stage of onset of the penetrance of these mutations, and aid future molecular phenotyping studies of 190 these disorders ( Supplementary Figure 2) . 191 192
Validation of markers and cell states 193
We derived 150 cluster-defining marker genes (Extended Data Methods), which we manually trimmed to 48 genes (Figure 2a ), where the limited set is still capable of 195 discriminating all 28 cell states. To assess the relative performance of the 150-gene versus 48-gene list 196 to classify cells, we used the ensemble learning random forest method, which gave 92% and 88% 197 average precision for their respective ability to identify cells (Figure 2b ). We selected genes encoding 198 surface proteins (denoted by * in Figure 2a (Figure 2d ). Although the relative proportion 214 of haematopoietic cells approximated our scRNA-seq profile, there were more hepatocytes observed 215 by imaging mass cytometry (Figure 2d and Figure 1c ). This is in keeping with published data on the 216 fragility of hepatocytes following ex vivo isolation and high expression of mitochondrial genes (up to 217 datasets with multiple modalities including flow cytometry, morphology and imaging mass cytometry 219 for spatial resolution, we provide an integrated map of haematopoietic cells in the fetal liver. 220 221
Fetal liver and NLT haematopoiesis 222
Following ab initio identification of fetal liver cells, we leveraged the real-time data from liver samples 223 across the gestational stages to infer developmental trajectories of fetal liver haematopoietic cells. For 224 all lineages, we used three different computational approaches (force-directed graph, diffusion map and 225 approximate graph abstraction (AGA) using Scanpy) and derived differentially expressed genes over 226 pseudotime using Monocle. Force-directed graph visualisation guided us to identify three distinct 227 connections to a central HSC/MPP node (Figure 3a We next focused on each of the three haematopoietic branches radiating from the HSC/MPP node in 234 fetal liver and interrogated their relationship to haematopoietic cells in fetal NLT (skin and kidney) 235 ( Figure 3a and Supplementary Figure 3b ). For comparison between fetal liver and NLT haematopoietic 236 cells, we used AGA scores to evaluate similarities across tissues and assessed the differentially 237 expressed genes between tissue counterparts (see Methods). In the fetal liver, all three trajectory 238 inference approaches reveal a consistent result, inferring mast cells, erythroid and megakaryocyte 239 lineages origin from a shared progenitor downstream of HSC/MPP, the putative megakaryocyte-240 erythroid-mast cell progenitor (MEMP) ( Figure 3b and Extended Data Figure 3a ). The unexpected 241 observation of mast cell coupling with erythroid fate is in keeping with observations of mast cell and 242 basophil origin during murine bone marrow and human cord blood haematopoiesis 19,20 . However, yolk 243 sac-derived mast cells have also been observed in murine skin and connective tissues suggesting 244 potential alternative origin for mast cells in NLT [19] [20] [21] [22] . 245
246
We can discern three transcriptionally distinct stages of erythroid development across a continuum 247 characterised by early, mid and late erythroblasts, with variable expression of haemoglobin genes 248 ( Figure 1c and Extended Data Figure 3b ). As fetal liver erythropoiesis is known to be supported by 249 adhesive interactions within erythroblastic islands ( Figure 3c ) 23 , we used a quantitative statistical 250 method (cellphonedb.org and Vento-Tormo et al., Nature In press) to predict cell surface receptor-251 ligand interactions between erythroblasts and erythroblastic island (EI) macrophages. Our analysis 252 identified molecules previously implicated in haematopoiesis such as VCAM1, ITGB1, ITGB2, ITGA4, 253 molecules as supporting the differentiation of erythroblasts by EI macrophages (Figure 3d ). 255
256
We next evaluated the genes that were differentially regulated during the transition of HSC/MPPs into 257 erythroid cells, megakaryocytes and mast cells (Extended Data Figure 3c ). Genes dynamically 258 expressed during erythroid differentiation include the known transcription factors (TFs) TAL1 and 259 GATA2; BPGM, which binds haemoglobin and the glycolysis enzyme PKLR (Extended Data Figure  260 3c) 29, 30 . 261
262
In contrast, megakaryocyte differentiation involves temporal regulation of F2R, PBX1 and MEIS1, the 263 latter known to dimerise and activate platelet factor 4 (PF4) (Extended Data Figure 3c ) 31 . Interestingly, 264
we show that HES1, previously reported to drive mast cell differentiation through Notch signalling is 265 dynamically regulated during fetal liver mast cell differentiation (Extended Data Figure 3c Furthermore, in contrast to fetal liver and kidney, putative MEMP in skin also express some early 290 9 erythroblast genes including MYL4 (Figure 3e ) 33,34 , suggesting that these may act as progenitors in situ 291 in the skin. These findings imply that during early development, the skin in physiological state can 292 contribute to erythropoiesis and supplement fetal liver erythroid output. The TRDC/TRAC expressing cells lack GZMB and PRF1, the cytoplasmic granular products 312 characteristic of mature CD8 + T cells ( Figure 4b and Extended Data 4c). These findings are in keeping 313 with the seeding of fetal liver by T cells and T cells sequentially following their exit from thymus 314 after 12 PCW 41 . This is consistent with previous reports of T cell identification only after 18 PCW 40, 42 . 315
316
Using diffusion map and AGA analyses, we show that NK cells (characterised by NCAM1, EOMES, 317 CD7, IL2R and CD3E) and ILC precursors (characterised by KIT, KLRB1, IL7R, ID2, AHR, RORC but 318 lack IL2R, TBX21, IL1RL1 (ST2)) are connected via the lymphoid branch (Figure 2a Data Figure 5a ). The earliest neutrophil myeloid progenitor expresses CD34, SPINK2, and known 367 myeloid markers including GATA2, ELANE, MPO and LYZ (Figure 2a ). Monocyte-DC precursors 368 share expression of monocytes and DC genes S100A9, CD1C and LYZ but do not express CD14. 369
Monocytes express CD14, S100A9, CD68 but not CD1C. Conventional DCs express the canonical 370 markers for the respective subsets; CD1C in DC2 and CLEC9A, CADM1 and XCR1 in DC1 ( Figure  371 Figure 5b ). Tissue-specific differences in gene expression were most notable 398 in macrophages: there is unique expression of VCAM1 and F13A1 in liver 26 and skin 59 macrophages 399 respectively, resembling the profile of adult macrophages in these respective tissues (Figure 5d ). 400 NLT pDCs and cDCs express DC maturation and activation markers compared to fetal liver DCs 402 ( Figure 5d and Extended Data Figure 5c ). Skin pDCs had a higher expression of MHC-II genes, 403 CLEC4C (CD303) and NRP1 (CD304) than fetal liver pDCs, suggesting a more mature state ( Figure  404 5d and Extended Data Figure 5c ). DC1 in skin express more S100A4, a molecule involved in T cell 405 activation, than liver DC1. The expression of AOAH, an enzyme involved in lipopolysaccharide 406 response modulation, was more specific to liver DC2, while skin DC2 expressed more Figure 6e ). The proportion of colonies derived from 439 CD34 + CD38 -CD45RAsingle cells containing NK cells significantly increased with gestational age, 440 whilst the proportion of colonies containing erythroid/megakaryocytic cells significantly decreased 441 (Extended Data Figure 6f ). 442
443
We propose this differentiation skew as an HSC/MPP-intrinsic property, since liquid culture conditions 444 without stroma produced the same ratios in output (Extended Data Figure 6g ). We also observed a 445 trend towards reduced multipotentiality with increased gestational age (Extended Data Figure 6e ). 446
These findings support the hypothesis of differential HSC/MPP intrinsic potential by gestational stage 447 and is in keeping with our earlier observation of the relative decrease in erythroid cells during 448 development ( Figure 1d The development of the human immune system in utero has remained poorly understood. Previous 476 studies have generally focused on a single immune cell type or lineage, and deployed markers of adult 477 immune cells to identify fetal immune cells. Using single cell transcriptome profiling, we were able to 478 overcome prior assumptions that adult markers faithfully identify fetal cells and resolve the cellular 479 heterogeneity within human fetal liver. Analysis of fetal liver, skin and kidney over gestation enabled 480 us to abstract dynamic temporal information across tissues to comprehensively establish the 481 haematopoietic and immune cell composition during fetal liver haematopoiesis. 482
483
We demonstrate the power and validity of transcriptome-based cell classification by integrating the data 484 with multiple modalities: FACS, Giemsa staining for morphology, and imaging mass cytometry-based 485 multiplex protein measurements. These methods allow for cost-effective and scalable isolation of cell 486 types, and analysis of their spatial localisation. 487
488
Our approach highlights key insights; intimate linking of mast cell origin with erythro-489 megakaryopoiesis, erythropoiesis in fetal skin as a normal feature rather than stress-response to disease, 490 establishment of DC network as early as 6 PCW, potential dual myeloid and lymphoid origin of pDCs 491 and tissue adaptation of NKs, ILCs, DCs and macrophages during development. Our findings reveal 492 modulation of HSC/MPP intrinsic differentiation potential over gestation age as a functional 493 mechanism to regulate haematopoietic output of the fetal liver throughout the first and second 494 trimesters. 495 496 While the fetal liver represents the primary site of fetal erythropoiesis, our data suggest that fetal skin 497 also contain proliferating erythroid progenitors which are likely to contribute to the high demand for 498 blood development in the fetus. This is supported by the presence of skin lesions containing 499 extramedullary haematopoiesis in fetuses and neonates with severe fetal anaemia 68 . Although the 500 percentage of erythroid lineage cells in skin is 1% of that in fetal liver, the total skin surface area of a 501 fetus would support a significant contribution to erythropoiesis particularly in the setting of increased 502 erythropoietic need. Extramedullary haematopoiesis in the skin may also occur in congenital 503 leukaemias, congenital CMV infection and in adults with myelofibrosis where megakaryocyte-504 containing papules are observed 69 . Circulating primitive erythroblasts have been observed in the 505 mouse 70 and significant platelet biogenesis in the post-natal murine lung has also been previously 506 reported 71 . 507
508
The presence of MEMP, megakaryocyte and erythroid cells at different maturation stages in 6-12 PCW 509 NLT suggest local maturation of progenitors, or extrahepatic haematopoiesis. The acquisition of tissue-510 specific molecular features is well recognised for myeloid and lymphoid cells including ILCs and T 511 15 cells 49, 72, 73 . This may relate to functional adaptation of myeloid and lymphoid cells but a more generic 512 function across tissues for mast cells, which are transcriptionally unaffected by their local tissue 513 microenvironment. 514
515
In summary, our comprehensive atlas of human fetal liver blood and immune cells provides a 516 foundational resource for understanding fetal liver haematopoiesis and the developing immune system. 517
Our reference dataset will be invaluable for studies on paediatric blood and immune disorders and 518 exploiting HSC/MPPs for therapy. Our approach using single cell transcriptomics to study human 519 development provides a framework that can be applied to study any temporal processes across the 520 human lifespan. All tissues were processed immediately after isolation using the same protocol. Tissue was transferred 740 to a sterile 10mm 2 tissue culture dish and cut into <1mm 3 segments before being transferred to a 50mL 741 conical tube. Tissue was digested with 1.6mg/mL collagenase type IV (Worthington) in RPMI (Sigma- Frozen suspended cells from human fetal livers (F15 and F18) were thawed, counted and split for 774 staining with two separate panels (see Supplementary Table 2 for antibody details). Cells were stained 775 for 30 minutes on ice followed by DAPI staining. FACS was performed on a BD FACSAria™ Fusion 776 instrument using DIVAv8, and data analysed using FlowJov10 2 frozen F18, F19). Populations were identified from the DAPI -, doublet-excluded gate as 796 CD3/CD16/CD11c/CD14/CD19/CD56 -, CD34 + cells (see Supplementary Table 3 for antibody details). 797
The HSC/MPP pool and MLP were found within the 20% of cells with lowest CD38 expression: 798 HSC/MPP pool were CD90 +/and CD45RAwhilst MLP were CD90 -CD45RA + . Progenitors with the 799 highest 20% of CD38 expression were sorted for comparison. Single cells were sorted using a BD 800
FACSAria™ Fusion operating DIVAv8, and sorted directly onto MS5 for culture, or into 96-well lo-801 bind plates containing 10 μl/well lysis buffer for Smart-seq2 scRNAseq. Single-cell-derived colonies 802 analysis was performed as described by the Laurenti Lab 63 . In brief, colonies were harvested into 96 803 μl/well of above antibody cocktail, incubated for 20 min in the dark at room temperature and then 805 washed with 100 μl/well of PBS + 3% FBS. The type (lineage composition) and the size of the colonies 806 formed were assessed by high-throughput flow cytometry (BD FACS Symphony). Colony output was 807 determined using the gating strategy shown in Extended Data Figure 6d Formalin fixed, paraffin embedded blocks of fetal livers aged 6PCW, 8PCW, 10PCW and 13PCW were 842 obtained from the HDBR. Each was sectioned at 4μm thickness onto APES-coated slides. Sections were 843 dewaxed for 5 minutes in Xylene (Fisher Chemical) then rehydrated through graded ethanol (99%, 95% 844 and 70%; Fisher Chemical) and washed in running water. Sections were treated with hydrogen peroxide 845 block (1%v/v in water; Sigma) for 10 minutes and rinsed in tap water prior to antigen retrieval. Citrate 846 antigen retrieval was used for all sections. Citrate buffer, pH6 was used with pressure heating for antigen 847 retrieval, and then slides placed in TBS, pH7.6 for 5 minutes prior to staining. Staining was done using 848 the Vector Immpress Kit (Vector Laboratories). Sections were blot dried and blocked sequentially with 849 2.5% normal horse serum, avidin (Vector Laboratories) and then biotin (Vector Laboratories) for 10 850 minutes each and blot dried in between. Sections were incubated for 60 minutes with primary antibody 851 diluted in TBS pH7.6 (see Supplementary Table 4 for antibody details). Slides were washed twice in 852 TBS pH7.6 for 5 minutes each before incubation for 30 minutes with the secondary antibody supplied 853 with the kit. Slides were washed twice in TBS pH7.6 for 5 minutes each, and developed using 854 peroxidase chromogen DAB. Sections were counterstained in Mayer's Haematoxylin for 30 seconds, 855 washed and put in scots tap water for 30 seconds. Slides were dehydrated through graded ethanol (70% 856 to 99%) and then placed in Xylene prior to mounting with DPX (Sigma-Aldrich). Sections were imaged 857 on a Nikon Eclipse 80i microscope using NIS-Elements Fv4. 858 859
Alignment, quantification and quality control of scRNA-seq data 860
Droplet-based (10x) sequencing data was aligned and quantified using the Cell Ranger Single-Cell 861 Software Suite (version 2.0.2, 10x Genomics Inc) using the GRCh38 human reference genome (official 862 Cell Ranger reference, version 1.2.0). Smart-seq2 sequencing data was aligned with STAR (version 863 2.5.1b), using the STAR index and annotation from the same reference as the 10x data. Gene-specific 864 read counts were calculated using htseq-count (version 0.10.0). Cells with fewer than 200 detected 865 genes and for which the total mitochondrial gene expression exceeded 20% were removed. Genes that 866 were expressed in fewer than 3 cells were also removed. 867 868
Doublet detection by support vector machine classification 869
Doublet exclusion was applied using a support vector machine (SVM) algorithm trained on scRNA-seq 870 data and simulated doublets. Doublet data was obtained by randomly choosing pairs of cells and adding 871 their raw counts by gene. Every pair of cells originated from the same lane in order to avoid introducing 872 doublets that are unlikely to exist, i.e. between cells that were loaded in different lanes. The SVM was 873 trained in Python 3.6.3 using the SVC (support vector classifier) from the svm module in the sklearn 874 package (version 0.19.1). A grid search was applied during the training of the SVM models to optimise 875 its hyperparameters using the GridSearchCV class in sklearn. 876 learning approaches which use random forest, k-nearest neighbours and logistic regression. The 878 random forest when trained with grid search parameter optimization was overfitting the data predicting 879 close to 0% doublets. The logistic regression was underfitting suggesting that linear classifiers may not 880 be suited for the problem of doublet detection. The k-nearest neighbours while being the closest to 881 scrublet in terms of detection mechanism showed high dependency on manual parameter tuning thus 882 making it a subjective method. 883
884
The criteria for assessing a doublet detector were: 1) should detect a very low number of doublets or 885 none in the plate-based scRNA-seq data, 2) the identified doublets should not form a compact separate 886 cluster, and 3) doublets should have higher UMI and gene counts relative to the rest of data. Both 887 scrublet and the svm doublet detectors satisfied the 3 criteria the difference being however that scrublet 888 predicted a much lower percentage of doublets (< 1%) while the svm detector predicted rates of 4-6 % 889 which are much closer to previously reported values 78 . In addition, we observed that the svm doublet 890 detector had the capacity to remove more of the outliers, which if present, distort diffusion maps. Random forest showed 94% for both accuracy and recall. Logistic regression with both l1 and l2 918 regularization showed 92% accuracy/recall. The lower performance of logistic regression classifiers 919 relative to the other 2 was attributed to lower ability of differentiating some of the early progenitors and 920 cell types within the myeloid compartment. The classifier was used for automatic annotation of the 921 Smart-seq2 data sets to allow identification of biologically meaningful clusters and DEG computation. 922 923 Data generated from fetal skin and kidney was pre-processed, normalised, clustered and manually 924 annotated, in parallel with, and using the same pipeline as, the liver data. Skin and kidney data were 925 combined using the MergeSeurat function. Clusters characterised by differentially expressed immune 926 gene markers were extracted from the NLT dataset for subsequent comparative analysis with liver-927 derived immune populations. Human cord blood and adult bone marrow datasets were downloaded 928 from Human Cell Atlas data portal (https://preview.data.humancellatlas.org/). These were processed 929 using the same approach as described above, followed by manual annotation. Alignment of datasets 930 differing in sequencing technology and batch correction were done by canonical correlation analysis 931 (runCCA, Seurat). For the receptor-ligand analysis in Figure 3d , a list of curated receptor-ligand interactions was retrieved 994 from CellPhoneDB (www.CellPhoneDB.org). The interactions whose receptor and ligand genes had 995 nonzero expression in at least 30% of cells within two cell types, respectively, were considered valid. 996
Receptor-ligand interactions between VCAM1 + Erythroblastic Island macrophages and the two 997 erythroid (early, mid) populations were listed. 998 999
Whole genome sequencing and fetal cell identification 1000
To identify maternal cells present in our data we combined the information from fetal whole genome 1001 DNA sequencing with the single cell RNA-seq data. For each sample we measured the allele frequency 1002 in the fetal DNA of SNPs from the 1000 genomes project 81 falling within exons with a population allele 1003 frequency in excess of 1%. We then consider only those SNPs which are homozygous in the fetal DNA 1004 for follow up in the scRNA-seq data. A SNP was considered to be homozygous if its allele frequency 1005 in the fetal DNA was less than 0.2 or greater than 0.8 and had an FDR adjusted p-value of less than 1006 0.01 under a binomial test for the null hypothesis that the allele frequency in the DNA was in the range 1007 [0.3,0.7]. 1008
1009
The allele frequency of each of these SNPs with population allele frequency > 1% that are known to be 1010 homozygous in the fetal DNA was then measured in each cell in the scRNA-seq data. Any deviations 1011 from homozygosity in the RNA-seq data must be a consequence of either sequencing errors, RNA 1012 editing, or the genotype of the cell differing from the fetal DNA. For each cell, we calculated the total 1013 fraction of reads at the SNPs (selected as described above) that differ from the fetal genotype. We then 1014 assume that the genome-wide rate of deviations due to sequencing errors and RNA editing is less than 1015 or equal to 2%. For maternal cells, the expected genome wide rate of deviation at these SNPs is equal 1016 to half the mean of the population allele frequency at the interrogated SNPs. Finally, for each cell we 1017 calculated the posterior probability of the cell being fetal or maternal assuming a binomial distribution 1018 with rate 2% for a fetal cell and half the mean of the population allele frequency for the maternal cell 1019 and assign a cell as: maternal/fetal if either posterior probability exceeds 99%, ambiguous otherwise. 1020
We validated this method using samples for which both the fetal and maternal DNA were available. 
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